Source: Annual Congress 2005 - Cystic fibrosis: genes, inflammation and more
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. L. Pukhalsky, G. V. Shmarina, K. A. Zykov, D. A. Pukhalskaya, N. I. Kapranov (Moscow, Russian Federation). Disturbance of pro-inflammatory cytokine production in patients with cystic fibrosis lung disease. Eur Respir J 2005; 26: Suppl. 49, 2578

Member's Comments

No comment yet.

Related content which might interest you: Circulating inflammatory cytokines in adult cystic fibrosis patients Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research Year: 2009 Pro-inflammatory cytokines in cystic fibrosis lungs Source: Eur Respir J 2005; 26: Suppl. 49, 403s Year: 2005 Cytokine production in whole blood and disease severity in cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 125s Year: 2001 Increased CCL18 production in interstitial lung diseases is associated with fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 38s Year: 2004 The role of chemokines and cytokines in lung fibrosis Source: Eur Respir Rev 2008; 17: 151-156 Year: 2008 The cytokine interleukin-17 is raised in the airway of people with cystic fibrosis Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease Source: Eur Respir J 2011; 37: 1378-1385 Year: 2011 Aspergillus-induced superoxide production by cystic fibrosis phagocytes is associated with disease severity Source: ERJ Open Res, 4 (2) 00068-2017; 10.1183/23120541.00068-2017 Year: 2018 Increased epithelial production of LPLUNC1 in cystic fibrosis lung disease Source: Annual Congress 2011 - Epithelial cell biology Year: 2011 IL-17A from innate and adaptive lymphocytes contributes to inflammation and damage in cystic fibrosis lung disease Source: Eur Respir J, 57 (6) 1900716; 10.1183/13993003.00716-2019 Year: 2021 Proinflammatory cytokines production in patients with purulent destructive lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 105s Year: 2001 Anti-inflammatory cytokines in cystic fibrosis lung disease Source: Eur Respir J 2006; 28: 581-587 Year: 2006 Alveolar macrophage oxidative and pro-inflammatory cytokine activity in lung sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 332s Year: 2005 The levels of proinflammatory cytokines in patients with dust-induced lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 536s Year: 2001 Season dynamics of inflammatory markers in patients with cystic fibrosis lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 528s Year: 2002 The chemokine decoy PA401 decreases interleukin-8 and chemotactic activity of cystic fibrosis airway samples Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013 Differential expression of IL-33 and HMGB1 in the lungs of stable cystic fibrosis patients Source: Eur Respir J 2014; 44: 802-805 Year: 2014 Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis Source: Eur Respir J 2009; 34: 655 Year: 2009 Role of IL23 in the development of fibrotic interstitial lung disease Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 Role of TGF-beta and IFN-gamma in interstitial pulmonary fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 719s Year: 2004